BLC
ACAD icon

Brown, Lisle/Cummings’s Acadia Pharmaceuticals ACAD Stock Holding History

Brown, Lisle/Cummings’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$10.8K Hold
500
– – ﹤0.01% 496
2025
Q1 		$8.31K Hold
500
– – ﹤0.01% 513
2024
Q4 		$9.18K Buy
500
+250
+100% +$4.59K ﹤0.01% 494
2024
Q3 		$3.85K Hold
250
– – ﹤0.01% 533
2024
Q2 		$4.06K Buy
+250
New +$4.06K ﹤0.01% 521